We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cytology Predicts Infections in Pulmonary Lesions

By LabMedica International staff writers
Posted on 11 Nov 2010
The examination of pulmonary fine-needle aspiration biopsy specimens by a cytopathologist aids in identifying the infectious organisms in pulmonary lesions. More...


Fine-needle aspiration biopsy (FNAB) of the lung is an invasive procedure commonly used to evaluate localized lesions, and can be used in determining the diagnosis of infectious causes before bacterial cultures yield results.

In a retrospective study carried out at the University of California, San Francisco (UCSF; San Francisco, CA, USA), scientists reviewed 820 FNABs that were performed on patients with pulmonary nodules over a 10-year study period. All samples were sent for cytopathologic evaluation and 80 (10%) FNABs were also sent for microbiologic culture. There were 24 samples with positive culture results (30%) comprising 28 organisms with two samples yielding two organisms and one with three organisms isolated. Eighteen isolates were bacterial, five were fungal, and five were mycobacterial. Seventeen samples (21%) yielded organisms considered potentially clinically significant, whereas seven (9%) were likely contaminants.

Cytopathologic findings associated with infectious etiologies (inflammatory cells, necrotic debris, and/or microbial organisms) were seen in all but four culture-positive cases, and three of these yielded contaminant organisms. Using culture as the gold standard and excluding contaminant organisms, sensitivity and specificity of cytology were 94% and 43%, with positive and negative predictive values of 33% and 96%, respectively. Cytology predicted positive cultures in all cases where organisms were visualized, and it was associated with negative cultures in 24 of 25 cases where inflammatory changes and necrosis were absent.

The authors of the study concluded that cytological results are often available more rapidly than cultures, particularly for slowly growing organisms, and may be used to guide treatment decisions before definitive culture diagnosis. The study was published in November 2010 in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
University of California, San Francisco




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.